Volume 149, Issue 3, Pages e4 (September 2015)

Slides:



Advertisements
Similar presentations
Hepatic Vascular Endothelial Growth Factor Regulates Recruitment of Rat Liver Sinusoidal Endothelial Cell Progenitor Cells Lin Wang, Xiangdong Wang, Lei.
Advertisements

Volume 152, Issue 4, Pages e2 (March 2017)
The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis  Janneke van Grinsven, Sandra van Brunschot  Gastroenterology 
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis  Marjolein Sikkema, Pieter.
Covering the Cover Gastroenterology
Shiv K. Sarin, Cyriac A. Philips  Gastroenterology 
Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device 
An Unusual Cause of Lower Gastrointestinal Bleeding
Volume 154, Issue 3, Pages e18 (February 2018)
Christoph Lübbert, Babett Holler  Gastroenterology 
The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis  Janneke van Grinsven, Sandra van Brunschot  Gastroenterology 
Covering the Cover Gastroenterology
Volume 152, Issue 4, Pages e2 (March 2017)
Volume 137, Issue 5, Pages e2 (November 2009)
Covering the Cover Gastroenterology
Volume 141, Issue 5, Pages e1 (November 2011)
A Patient With Left Upper Abdominal Pain Who Had Petit Sac
Volume 149, Issue 3, Pages e3 (September 2015)
Body Composition and Barrett’s Esophagus
Volume 141, Issue 6, Pages (December 2011)
Cause-Specific Mortality of People With Barrett's Esophagus Compared With the General Population: A Population-Based Cohort Study  Masoud Solaymani–Dodaran,
Volume 154, Issue 8, Pages e5 (June 2018)
Volume 142, Issue 2, Pages (February 2012)
Unusual Thickened Gastric Folds in a Patient With Breast Cancer
Volume 144, Issue 1, Pages e6 (January 2013)
Volume 154, Issue 4, Pages e1 (March 2018)
Volume 154, Issue 1, Pages e20 (January 2018)
Unusual Case of an Upset Stomach
Patients With Barrett’s Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer  Christine Kestens, G.
Volume 149, Issue 6, Pages e1 (November 2015)
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 135, Issue 4, Pages (October 2008)
Volume 150, Issue 4, Pages (April 2016)
Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis  Sonja Kroep,
Progressive Dysphagia in a Pregnant Woman
Sibu Varghese, Pierre Lao–Sirieix, Rebecca C. Fitzgerald 
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis  Marjolein Sikkema, Pieter.
Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening  Iris Lansdorp-Vogelaar,
Endoscopic Therapy for Barrett's Esophagus
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
Coffee and Colorectal Cancer: Grounds for Prevention?
Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients  Elena M. Stoffel, Anu Chittenden 
An Unlikely Lesion to Be Identified in the Cervical Esophagus
Hashem El–Serag, Anna S.F. Lok, David L. Thomas  Gastroenterology 
Incidence of Progression of Persistent Nondysplastic Barrett’s Esophagus to Malignancy  Yonne Peters, Judith Honing, Wietske Kievit, Christine Kestens,
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Jeremy P. Dwyer, Patrick Hosking, John Lubel  Gastroenterology 
Volume 155, Issue 5, Pages e5 (November 2018)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
The Dawning of a New Editorial Board for Gastroenterology
Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo  Barjesh Chander Sharma, Praveen.
Baby-Epsilon Steps Toward the Triple Aim
Cost Utility of Screening for Barrett’s Esophagus With Esophageal Capsule Endoscopy Versus Conventional Upper Endoscopy  Joel H. Rubenstein, John M. Inadomi,
Risks Associated With Anesthesia Services During Colonoscopy
A “Crescent-in-doughnut” Lesion at Right Lower Quadrant Abdomen
Volume 156, Issue 4, Pages (March 2019)
Daniel Mønsted Shabanzadeh, Lars Tue Sørensen, Torben Jørgensen 
Volume 139, Issue 6, Pages e1 (December 2010)
Cancer Costs Projected to Reach at Least $158 Billion in 2020
Volume 138, Issue 6, Pages (May 2010)
Covering the Cover Gastroenterology
A Necrotic Liver Mass Gastroenterology
Shiv K. Sarin, Cyriac A. Philips  Gastroenterology 
Volume 145, Issue 3, Pages e1 (September 2013)
Electronic Clinical Challenges and Images in GI
The Future of Endoscopic Retrograde Cholangiopancreatography
A Female Patient With Persistent Epigastric Pain for 1 Week
Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms  Wuqing Huang, Jan Sundquist,
Abnormal Gastrointestinal Imaging in a Patient With Dyspepsia
A Rare Tumor of the Liver With a Sudden Presentation
Presentation transcript:

Volume 149, Issue 3, Pages 577-585.e4 (September 2015) An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling  Sonja Kroep, Iris Lansdorp-Vogelaar, Joel H. Rubenstein, Harry J. de Koning, Reinier Meester, John M. Inadomi, Marjolein van Ballegooijen  Gastroenterology  Volume 149, Issue 3, Pages 577-585.e4 (September 2015) DOI: 10.1053/j.gastro.2015.04.045 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 Graphical representation of the Erasmus/UW Model. Gastroenterology 2015 149, 577-585.e4DOI: (10.1053/j.gastro.2015.04.045) Copyright © 2015 AGA Institute Terms and Conditions

Figure 2 Diagnostic inaccuracy of endoscopic surveillance in the main analysis of our model. Gastroenterology 2015 149, 577-585.e4DOI: (10.1053/j.gastro.2015.04.045) Copyright © 2015 AGA Institute Terms and Conditions

Figure 3 Cancer incidence rates for different lengths of follow-up in the realistic scenario. (A) Mean annual progression rates toward EAC and (B) cumulative cancer incidence toward EAC. Gastroenterology 2015 149, 577-585.e4DOI: (10.1053/j.gastro.2015.04.045) Copyright © 2015 AGA Institute Terms and Conditions

Figure 4 (Upper panel) Cancer incidence rates per 1000 BE patients for 20 years of follow-up in the population-based design without any surveillance (perfect surveillance scenario), in the population-based and prospective design for the realistic scenario. (Lower panel) Cumulative cancer incidence rates per 1000 BE patients for 20 years of follow-up in the population-based design without any surveillance (perfect surveillance scenario), in the population-based and prospective design for the realistic scenario. Gastroenterology 2015 149, 577-585.e4DOI: (10.1053/j.gastro.2015.04.045) Copyright © 2015 AGA Institute Terms and Conditions

Figure 5 HGD and cancer incidence rates for different lengths of follow-up in the realistic scenario. (A) Mean annual progression rates toward HGD and EAC and (B) cumulative cancer incidence toward HGD and EAC. Gastroenterology 2015 149, 577-585.e4DOI: (10.1053/j.gastro.2015.04.045) Copyright © 2015 AGA Institute Terms and Conditions

Figure 6 Cancer incidence rates for different lengths of follow-up in the sensitivity analysis. Perfect surveillance scenario: (A) mean annual progression rates toward EAC and (B) cumulative cancer incidence toward EAC. False-positive BE scenario: (C) mean annual progression rates toward EAC and (D) cumulative cancer incidence toward EAC. Halting surveillance scenario: (E) mean annual progression rates toward EAC and (F) cumulative cancer incidence toward EAC. Gastroenterology 2015 149, 577-585.e4DOI: (10.1053/j.gastro.2015.04.045) Copyright © 2015 AGA Institute Terms and Conditions

Supplementary Figure 1 Graphical representation of the natural history of EAC in the Erasmus/UW model. Gastroenterology 2015 149, 577-585.e4DOI: (10.1053/j.gastro.2015.04.045) Copyright © 2015 AGA Institute Terms and Conditions